Three-year results of denosumab treatment for osteoporosis in women with rheumatoid arthritis and primary osteoporosis: A clinical observational study.

Takeshi Mochizuki Koichiro Yano Katsunori Ikari Ryo HiroshimaYuki NasuKen Okazaki

Published in: Modern rheumatology (2020)

Denosumab treatment for osteoporosis had a similar efficacy over 3 years among women with RA and PO. A better understanding of denosumab treatment for this patient population is important in clinical practice.

Keyphrases

bone mineral density
rheumatoid arthritis
postmenopausal women
combination therapy
body composition
replacement therapy
visible light